We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CRISPR

News List

binx health™ Submits Request for Emergency Use Authorization for First CRISPR-based Point-of-care Test for COVID-19 prnewswire
May 19, 2021
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Turning CRISPR from a gene-editing hatchet to a ‘word processor’ fiercebiotech
May 08, 2018
For all the excitement the gene-editing tool CRISPR-Cas9 has kicked up, there has been just as much concern about unwanted side effects. That’s because even though the technology offers the promise of cutting out disease-causing gene...
Novartis, already up on CRISPR, CAR-T, looks to new gene editing R&D fiercebiotech
November 14, 2017
Novartis has penned a new deal with Homology Medicines as it looks to boost its already impressive R&D work in cell and gene therapy.